Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-12

Clinical Trial Update: Injection of an Autologous A2M Concentrate Alleviates Back Pain in FAC-positive Patients

View source ↗

Summary

A completed trial evaluating injections of autologous alpha-2-macroglobulin concentrate for low back pain reports alleviation of symptoms in FAC-positive patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous alpha-2-macroglobulin concentrate injection (alpha-2-macroglobulin concentrate)

Snippet

Sponsor: Scuderi, Gaetano J., M.D. | Conditions: Low Back Pain | Status: COMPLETED